4.4 Article

Immune regulation toward immunomodulation for neuroprotection in glaucoma

期刊

CURRENT OPINION IN PHARMACOLOGY
卷 13, 期 1, 页码 23-31

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2012.09.013

关键词

-

资金

  1. National Eye Institute, Bethesda, MD [R01 EY013813, R01 EY017131]
  2. Robert W. Rounsavall, Jr. Family Foundation, Inc.
  3. Research to Prevent Blindness Inc., New York, NY

向作者/读者索取更多资源

Although the immune system functions to preserve and restore tissue homeostasis, accumulating risk factors, prolonged glial activation, and sustained release of pro-inflammatory mediators in glaucoma may lead to a failure in the regulation of stress-induced immune response, and innate immune cells, autoreactive T cells, autoantibodies, and excess complement attack may exhibit potent stimuli that harm retinal ganglion cell somas, axons, and synapses. Identification of the cellular and molecular components of immune response pathways can provide immunomodulatory treatment strategies to attenuate neuroinflammation, protect neural tissue from collateral injury, and enhance endogenous recovery processes. This review highlights the current knowledge of molecular mechanisms regulating neuroinflammation in glaucoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据